EnWave Licenses New Products to Milne Fruit Products

VANCOUVER, BC--(Marketwired - August 13, 2015) - EnWave Corporation (TSX VENTURE: ENW) (FRANKFURT: E4U) ("EnWave", or the "Company") is pleased to announce that the Company has amended and expanded the existing commercial royalty-bearing license (the "License") with Milne Fruit Products ("Milne") to enable the commercial production of several new products including mint, sweet potato and beets using Radiant Energy Vacuum ("REV™") technology.

EnWave has agreed to grant Milne the right to produce these additional products due to Milne's recent positive sales momentum pertaining to its MicroDried^® ingredient line. Milne has ramped up their production to satisfy significant orders from several major food companies.

Milne's MicroDried^® ingredients are 100% all-natural, high quality dried fruit and vegetables that are rich in nutritional values and health benefits -- retaining higher levels of polyphenols than other commercial drying processes. MicroDried^® products bring real fruit color, flavor and enhanced nutritional values to consumer products. Milne currently offers MicroDried^® fruits and vegetables as whole or fragmented. Select products or varieties are available in both high and low moisture level offering different textures -- chewy and crunchy.

About Milne Fruit Products
Since 1956, Milne Fruit Products has been an industry leader in creating fruit juices, concentrates and purees from Concord grapes and has expanded its product line to include over 25 different all-natural fruit and vegetable varieties and more than 50 ingredient products. Today, Milne is an independent processor and global supplier for the industrial food ingredient, beverage and health and wellness markets. For more information on Milne Fruit Products please visit www.milnefruit.com.

About EnWave
EnWave Corporation is a Vancouver-based industrial technology company developing commercial applications for its proprietary Radiant Energy Vacuum (REV™) dehydration technology. EnWave aims to sign royalty-bearing commercial licenses with leading food and pharmaceutical companies for the use of its revolutionary technology. Thus far the Company has signed fifteen royalty-bearing licenses, opening up eight distinct market sectors for commercialization with companies. In addition to these licenses, EnWave has formed a Limited Liability Partnership, NutraDried LLP, to develop, manufacture, market and sell all-natural cheese snack products in the United States under the Moon Cheese^® brand.

EnWave is introducing REV™ as a new dehydration standard in the food and biological material sectors: potentially faster and cheaper than freeze drying, with better end product quality than air drying or spray drying. EnWave currently has three commercial REV™ platforms: nutraREV^® is used in the food industry to dry food products quickly, while maintaining high levels of nutrition, taste, texture and colour; powderREV^® is used for the bulk dehydration of food cultures, probiotics and fine biochemicals such as enzymes below the freezing point and quantaREV^® is used for continuous, high-volume low-temperature drying. Two additional platforms, bioREV^® and freezeREV^®, are being developed as new methods to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies. More information about EnWave is available at www.enwave.net.

EnWave Corporation
Dr. Tim Durance
President, CEO and Director

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third party claims referred to in this release are not guaranteed to be accurate. All third party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.